Stock Taper 
SILVERARC CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Cerus Corporation | CERS | 3.47M | $10.14M |
 C4 Therapeutics, Inc. | CCCC | 3.03M | $14.16M |
 Aclaris Therapeutics, Inc. | ACRS | 1.95M | $10.3M |
 Cogent Biosciences, Inc. | COGT | 1.28M | $49.56M |
 Erasca, Inc. | ERAS | 1.26M | $23.14M |
 Syndax Pharmaceuticals, Inc. | SNDX | 1.21M | $26.55M |
 Monte Rosa Therapeutics, Inc. | GLUE | 1.11M | $26.82M |
 ORIC Pharmaceuticals, Inc. | ORIC | 738.87K | $8M |
 Trevi Therapeutics, Inc. | TRVI | 678.1K | $12.65M |
 Solid Biosciences Inc. | SLDB | 668.45K | $6.68M |
 Immunovant, Inc. | IMVT | 619.1K | $23.85M |
 Kodiak Sciences Inc. | KOD | 546.26K | $21.28M |
 Zenas BioPharma, Inc. | ZBIO | 509.79K | $12.94M |
 COMPASS Pathways plc | CMPS | 503.38K | $7.12M |
 Celcuity Inc. | CELC | 501K | $52.41M |
 Enliven Therapeutics, Inc. | ELVN | 489.38K | $24.84M |
 Definium Therapeutics, Inc. | DFTX | 400K | $18.82M |
 Dianthus Therapeutics, Inc. | DNTH | 390K | $38.02M |
 Oruka Therapeutics, Inc. | ORKA | 352.8K | $33.58M |
 Avalyn Pharma Inc. Common Stock | AVLN | 330.49K | $10.88M |